{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:41:46Z","timestamp":1790649706436,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T00:00:00Z","timestamp":1283385600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Polycystic Kidney Disease is characterized by the formation of large fluid-filled cysts that eventually destroy the renal parenchyma leading to end-stage renal failure. Although remarkable progress has been made in understanding the pathologic mechanism of the disease, the precise orchestration of the early events leading to cyst formation is still unclear. Abnormal cellular proliferation was traditionally considered to be one of the primary irregularities leading to cyst initiation and growth. Consequently, many therapeutic interventions have focused on targeting this abnormal proliferation, and some have even progressed to clinical trials. However, the role of proliferation in cyst development was primarily examined at stages where cysts are already visible in the kidneys and therefore at later stages of disease development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study we focused on the cystic phenotype since birth in an attempt to clarify the temporal contribution of cellular proliferation in cyst development. Using a PKD2 transgenic rat model (PKD2 (1-703)) of different ages (0-60 days after birth) we performed gene expression profiling and phenotype analysis by measuring various kidney parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Phenotype analysis demonstrated that renal cysts appear immediately after birth in the PKD2 transgenic rat model (PKD2 (1-703)). On the other hand, abnormal proliferation occurs at later stages of the disease as identified by gene expression profiling. Interestingly, other pathways appear to be deregulated at early stages of the disease in this PKD model. Specifically, gene expression analysis demonstrated that at day 0 the RAS system is involved. This is altered at day 6, when Wnt signaling and focal adhesion pathways are affected. However, at and after 24 days, proliferation, apoptosis, altered ECM signaling and many other factors become involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggest that cystogenesis precedes deregulation of proliferation-related pathways, suggesting that proliferation abnormalities may contribute in cyst growth rather than cyst formation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-11-23","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T18:14:21Z","timestamp":1283451261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways"],"prefix":"10.1186","volume":"11","author":[{"given":"Panayiota","family":"Koupepidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriacos N","family":"Felekkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Kr\u00e4nzlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Deltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,2]]},"reference":[{"issue":"7","key":"174_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.ejhg.5200484","volume":"8","author":"C Badenas","year":"2000","unstructured":"Badenas C, Torra R, Perez-Oller L, Mallolas J, Talbot-Wright R, Torregrosa V, Darnell A: Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients. Eur J Hum Genet. 2000, 8 (7): 487-492. 10.1038\/sj.ejhg.5200484.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"174_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s004390050896","volume":"103","author":"M Koptides","year":"1998","unstructured":"Koptides M, Constantinides R, Kyriakides G, Hadjigavriel M, Patsalis PC, Pierides A, Constantinou Deltas C: Loss of heterozygosity in polycystic kidney disease with a missense mutation in the repeated region of PKD1. Hum Genet. 1998, 103 (6): 709-717. 10.1007\/s004390050896.","journal-title":"Hum Genet"},{"issue":"3","key":"174_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/hmg\/8.3.509","volume":"8","author":"M Koptides","year":"1999","unstructured":"Koptides M, Hadjimichael C, Koupepidou P, Pierides A, Constantinou Deltas C: Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet. 1999, 8 (3): 509-513. 10.1093\/hmg\/8.3.509.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"174_CR4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","volume":"10","author":"Y Pei","year":"1999","unstructured":"Pei Y, Watnick T, He N, Wang K, Liang YAN, Parfrey P, Germino G, George-Hyslop PS: Somatic PKD2 Mutations in Individual Kidney and Liver Cysts Support a \"Two-Hit\" Model of Cystogenesis in Type 2 Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 1999, 10 (7): 1524-1529.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"174_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/hmg\/9.3.447","volume":"9","author":"M Koptides","year":"2000","unstructured":"Koptides M, Mean R, Demetriou K, Pierides A, Deltas CC: Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet. 2000, 9 (3): 447-452. 10.1093\/hmg\/9.3.447.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"174_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/75981","volume":"25","author":"T Watnick","year":"2000","unstructured":"Watnick T, He N, Wang K, Liang Y, Parfrey P, Hefferton D, St George-Hyslop P, Germino G, Pei Y: Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet. 2000, 25 (2): 143-144. 10.1038\/75981.","journal-title":"Nat Genet"},{"issue":"12","key":"174_CR7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1681\/ASN.V3121841","volume":"3","author":"JJ Grantham","year":"1993","unstructured":"Grantham JJ: 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol. 1993, 3 (12): 1841-1857.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"174_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1046\/j.1523-1755.1999.00370.x","volume":"55","author":"NS Murcia","year":"1999","unstructured":"Murcia NS, Sweeney JWE, Avner ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int. 1999, 55 (4): 1187-1197. 10.1046\/j.1523-1755.1999.00370.x.","journal-title":"Kidney Int"},{"issue":"7","key":"174_CR9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.V571462","volume":"5","author":"T Nadasdy","year":"1995","unstructured":"Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol. 1995, 5 (7): 1462-1468.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"174_CR10","first-page":"1153","volume":"13","author":"J Lanoix","year":"1996","unstructured":"Lanoix J, D'Agati V, Szabolcs M, Trudel M: Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene. 1996, 13 (6): 1153-1160.","journal-title":"Oncogene"},{"issue":"5","key":"174_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(00)00123-4","volume":"6","author":"A Boletta","year":"2000","unstructured":"Boletta A, Qian F, Onuchic LF, Bhunia AK, Phakdeekitcharoen B, Hanaoka K, Guggino W, Monaco L, Germino GG: Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell. 2000, 6 (5): 1267-1273. 10.1016\/S1097-2765(00)00123-4.","journal-title":"Mol Cell"},{"issue":"6","key":"174_CR12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1681\/ASN.V96937","volume":"9","author":"K Ramasubbu","year":"1998","unstructured":"Ramasubbu K, Gretz N, Bachmann S: Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol. 1998, 9 (6): 937-945.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"174_CR13","first-page":"607","volume":"11","author":"PD Wilson","year":"1991","unstructured":"Wilson PD: Cell biology of human autosomal dominant polycystic kidney disease. Semin Nephrol. 1991, 11 (6): 607-616.","journal-title":"Semin Nephrol"},{"issue":"4","key":"174_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1152\/physiol.00003.2004","volume":"19","author":"Q Zhang","year":"2004","unstructured":"Zhang Q, Taulman PD, Yoder BK: Cystic Kidney Diseases: All Roads Lead to the Cilium. Physiology. 2004, 19 (4): 225-230. 10.1152\/physiol.00003.2004.","journal-title":"Physiology"},{"issue":"6","key":"174_CR15","doi-asserted-by":"publisher","first-page":"F1159","DOI":"10.1152\/ajprenal.00118.2005","volume":"289","author":"JR Davenport","year":"2005","unstructured":"Davenport JR, Yoder BK: An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol. 2005, 289 (6): F1159-1169. 10.1152\/ajprenal.00118.2005.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"174_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med. 2004, 10 (4): 363-364. 10.1038\/nm1004.","journal-title":"Nat Med"},{"issue":"4","key":"174_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang X, Gattone V, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol. 2005, 16 (4): 846-851. 10.1681\/ASN.2004121090.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"174_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2215\/CJN.00060108","volume":"3","author":"AB Chapman","year":"2008","unstructured":"Chapman AB: Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol. 2008, 3 (4): 1197-1204. 10.2215\/CJN.00060108.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"174_CR19","doi-asserted-by":"publisher","first-page":"F854","DOI":"10.1152\/ajprenal.00059.2007","volume":"293","author":"I Zafar","year":"2007","unstructured":"Zafar I, Tao Y, Falk S, McFann K, Schrier RW, Edelstein CL: Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model. Am J Physiol Renal Physiol. 2007, 293 (3): F854-859. 10.1152\/ajprenal.00059.2007.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"14","key":"174_CR20","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A: The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA. 2006, 103 (14): 5466-5471. 10.1073\/pnas.0509694103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"174_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Schrier RW, Edelstein CL: Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol. 2005, 16 (1): 46-51. 10.1681\/ASN.2004080660.","journal-title":"J Am Soc Nephrol"},{"issue":"7121","key":"174_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature05348","volume":"444","author":"NO Bukanov","year":"2006","unstructured":"Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O: Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature. 2006, 444 (7121): 949-952. 10.1038\/nature05348.","journal-title":"Nature"},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0070-2153(08)00606-6","volume":"84","author":"PD Wilson","year":"2008","unstructured":"Wilson PD: Mouse models of polycystic kidney disease. Curr Top Dev Biol. 2008, 84: 311-350. full_text.","journal-title":"Curr Top Dev Biol"},{"issue":"2","key":"174_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"AK Bhunia","year":"2002","unstructured":"Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN, Germino FJ, Germino GG: PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell. 2002, 109 (2): 157-168. 10.1016\/S0092-8674(02)00716-X.","journal-title":"Cell"},{"issue":"12","key":"174_CR25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ncb1326","volume":"7","author":"X Li","year":"2005","unstructured":"Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J: Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol. 2005, 7 (12): 1202-1212. 10.1038\/ncb1326.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"174_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2369-9-10","volume":"9","author":"KN Felekkis","year":"2008","unstructured":"Felekkis KN, Koupepidou P, Kastanos E, Witzgall R, Bai CX, Li L, Tsiokas L, Gretz N, Deltas C: Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1\/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2. BMC Nephrol. 2008, 9 (1): 10-10.1186\/1471-2369-9-10.","journal-title":"BMC Nephrol"},{"issue":"12","key":"174_CR27","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007, 13 (12): 1490-1495. 10.1038\/nm1675.","journal-title":"Nat Med"},{"issue":"10","key":"174_CR28","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1681\/ASN.2005090979","volume":"17","author":"AR Gallagher","year":"2006","unstructured":"Gallagher AR, Hoffmann S, Brown N, Cedzich A, Meruvu S, Podlich D, Feng Y, Konecke V, de Vries U, Hammes H-P, et al: A Truncated Polycystin-2 Protein Causes Polycystic Kidney Disease and Retinal Degeneration in Transgenic Rats. J Am Soc Nephrol. 2006, 17 (10): 2719-2730. 10.1681\/ASN.2005090979.","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"174_CR29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/hmg\/11.18.2165","volume":"11","author":"MT Bihoreau","year":"2002","unstructured":"Bihoreau MT, Megel N, Brown JH, Kranzlin B, Crombez L, Tychinskaya Y, Broxholme J, Kratz S, Bergmann V, Hoffman S, et al: Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy\/+) rat in a region conserved with a mouse modifier locus for Alport syndrome. Hum Mol Genet. 2002, 11 (18): 2165-2173. 10.1093\/hmg\/11.18.2165.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"174_CR30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/genetics\/165.2.747","volume":"165","author":"WP Hsieh","year":"2003","unstructured":"Hsieh WP, Chu TM, Wolfinger RD, Gibson G: Mixed-model reanalysis of primate data suggests tissue and species biases in oligonucleotide-based gene expression profiles. Genetics. 2003, 165 (2): 747-757.","journal-title":"Genetics"},{"issue":"2","key":"174_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/10543400601001600","volume":"17","author":"J Roy","year":"2007","unstructured":"Roy J: SAS for mixed models. J Biopharm Stat. 2007, 17 (2): 363-365. 10.1080\/10543400601001600.","journal-title":"J Biopharm Stat"},{"issue":"43","key":"174_CR32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102 (43): 15545-15550. 10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"174_CR33","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1093\/bioinformatics\/btl424","volume":"22","author":"T Manoli","year":"2006","unstructured":"Manoli T, Gretz N, Grone HJ, Kenzelmann M, Eils R, Brors B: Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics. 2006, 22 (20): 2500-2506. 10.1093\/bioinformatics\/btl424.","journal-title":"Bioinformatics"},{"issue":"42","key":"174_CR34","doi-asserted-by":"publisher","first-page":"28471","DOI":"10.1074\/jbc.M803834200","volume":"283","author":"S Feng","year":"2008","unstructured":"Feng S, Okenka GM, Bai CX, Streets AJ, Newby LJ, DeChant BT, Tsiokas L, Obara T, Ong AC: Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2. J Biol Chem. 2008, 283 (42): 28471-28479. 10.1074\/jbc.M803834200.","journal-title":"J Biol Chem"},{"issue":"1","key":"174_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","volume":"57","author":"WE Sweeney","year":"2000","unstructured":"Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED: Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int. 2000, 57 (1): 33-40. 10.1046\/j.1523-1755.2000.00829.x.","journal-title":"Kidney Int"},{"issue":"5","key":"174_CR36","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","volume":"64","author":"VE Torres","year":"2003","unstructured":"Torres VE, Sweeney WE, Wang X, Qian Q, Harris PC, Frost P, Avner ED: EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int. 2003, 64 (5): 1573-1579. 10.1046\/j.1523-1755.2003.00256.x.","journal-title":"Kidney Int"},{"issue":"10","key":"174_CR37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone","year":"2003","unstructured":"Gattone VH, Wang X, Harris PC, Torres VE: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med. 2003, 9 (10): 1323-1326. 10.1038\/nm935.","journal-title":"Nat Med"},{"issue":"11","key":"174_CR38","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0700499104","volume":"104","author":"SJ Leuenroth","year":"2007","unstructured":"Leuenroth SJ, Okuhara D, Shotwell JD, Markowitz GS, Yu Z, Somlo S, Crews CM: Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proceedings of the National Academy of Sciences. 2007, 104 (11): 4389-4394. 10.1073\/pnas.0700499104.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"174_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.1987.121","volume":"31","author":"JJ Grantham","year":"1987","unstructured":"Grantham JJ, Geiser JL, Evan AP: Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 1987, 31 (5): 1145-1152. 10.1038\/ki.1987.121.","journal-title":"Kidney Int"},{"issue":"10","key":"174_CR40","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1681\/ASN.2005090979","volume":"17","author":"AR Gallagher","year":"2006","unstructured":"Gallagher AR, Hoffmann S, Brown N, Cedzich A, Meruvu S, Podlich D, Feng Y, Konecke V, de Vries U, Hammes HP, et al: A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats. J Am Soc Nephrol. 2006, 17 (10): 2719-2730. 10.1681\/ASN.2005090979.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"174_CR41","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007, 13 (12): 1490-1495. 10.1038\/nm1675.","journal-title":"Nat Med"},{"issue":"11","key":"174_CR42","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","volume":"17","author":"V Patel","year":"2008","unstructured":"Patel V, Li L, Cobo-Stark P, Shao X, Somlo S, Lin F, Igarashi P: Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet. 2008, 17 (11): 1578-1590. 10.1093\/hmg\/ddn045.","journal-title":"Hum Mol Genet"},{"key":"174_CR43","volume-title":"Hum Mol Genet","author":"H Happe","year":"2009","unstructured":"Happe H, Leonhard WN, Van der Wal A, Van de Water B, Lantinga-van Leeuwen IS, Breuning MH, De Heer E, Peters DJ: Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet. 2009,"},{"issue":"4","key":"174_CR44","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2353\/ajpath.2009.090227","volume":"175","author":"S Prasad","year":"2009","unstructured":"Prasad S, McDaid JP, Tam FW, Haylor JL, Ong AC: Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury. Am J Pathol. 2009, 175 (4): 1493-1503. 10.2353\/ajpath.2009.090227.","journal-title":"Am J Pathol"},{"issue":"8","key":"174_CR45","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ndt\/gfl150","volume":"21","author":"MY Chang","year":"2006","unstructured":"Chang MY, Parker E, Ibrahim S, Shortland JR, Nahas ME, Haylor JL, Ong AC: Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol Dial Transplant. 2006, 21 (8): 2078-2084. 10.1093\/ndt\/gfl150.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"174_CR46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00467-008-1021-9","volume":"24","author":"IV Yosypiv","year":"2009","unstructured":"Yosypiv IV: Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis. Pediatr Nephrol. 2009, 24 (6): 1113-1120. 10.1007\/s00467-008-1021-9.","journal-title":"Pediatr Nephrol"},{"key":"174_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/01.HYP.32.3.387","volume":"32","author":"NK Hollenberg","year":"1998","unstructured":"Hollenberg NK, Fisher ND, Price DA: Pathways for angiotensin II generation in intact human tissue: Evidence for comparative pharmacological interruption of the renin system. Hypertension. 1998, 32: 387-392.","journal-title":"Hypertension"},{"issue":"2","key":"174_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.ASN.0000109782.28991.26","volume":"15","author":"EA McPherson","year":"2004","unstructured":"McPherson EA, Luo Z, Brown RA, LeBard LS, Corless CC, Speth RC, Bagby SP: Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2004, 15 (2): 493-500. 10.1097\/01.ASN.0000109782.28991.26.","journal-title":"J Am Soc Nephrol"},{"key":"174_CR49","first-page":"F290","volume":"274","author":"RK Handa","year":"1998","unstructured":"Handa RK, L.T K, Harding JW, Handa SE: Angiotensin IV AT4-receptor system in the rat kidney. Am J Physiol. 1998, 274: F290-299.","journal-title":"Am J Physiol"},{"issue":"6","key":"174_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0196-9781(01)00405-3","volume":"22","author":"TA Hamilton","year":"2001","unstructured":"Hamilton TA, Handa RK, Harding JW, Wright JW: A role for the angiotensin IV\/AT4 system in mediating natriuresis in the rat. Peptides. 2001, 22 (6): 935-944. 10.1016\/S0196-9781(01)00405-3.","journal-title":"Peptides"},{"key":"174_CR51","doi-asserted-by":"crossref","first-page":"F980","DOI":"10.1152\/ajprenal.2001.280.6.F980","volume":"280","author":"JK Chen","year":"2001","unstructured":"Chen JK, Zimpelmann J, Harris RC, Burns KD: Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol. 2001, 280: F980-988.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"174_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.ki.5000062","volume":"69","author":"WM Bernhardt","year":"2006","unstructured":"Bernhardt WM, Schmitt R, Rosenberger C, Munchenhagen PM, Grone HJ, Frei U, Warnecke C, Bachmann S, Wiesener MS, Willam C, et al: Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int. 2006, 69 (1): 114-122. 10.1038\/sj.ki.5000062.","journal-title":"Kidney Int"},{"key":"174_CR53","volume-title":"Pediatr Nephrol","author":"IV Yosypiv","year":"2008","unstructured":"Yosypiv IV: Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis. Pediatr Nephrol. 2008"}],"updated-by":[{"DOI":"10.1186\/1471-2369-12-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T00:00:00Z","timestamp":1296604800000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-11-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-11-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T03:48:16Z","timestamp":1630468096000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-11-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-11-23","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,2]]},"assertion":[{"value":"14 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}